Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ziegler LinkAge Longevity Fund is a specialized venture capital fund focused on investing in companies that provide innovative solutions for the aging and senior living markets. A collaboration between the investment bank Ziegler and LinkAge, the fund targets technology-enabled products and services that improve the quality of life for older adults and enhance the efficiency of healthcare providers. Its portfolio typically includes companies in the digital health, health IT, and age-tech sectors, bridging the gap between senior living providers and emerging technology developers. The fund leverages a unique network of limited partners, primarily consisting of senior living and healthcare providers, to provide strategic value and market access to its portfolio companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ziegler LinkAge Longevity Fund.